IE38521B1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- IE38521B1 IE38521B1 IE2082/73A IE208273A IE38521B1 IE 38521 B1 IE38521 B1 IE 38521B1 IE 2082/73 A IE2082/73 A IE 2082/73A IE 208273 A IE208273 A IE 208273A IE 38521 B1 IE38521 B1 IE 38521B1
- Authority
- IE
- Ireland
- Prior art keywords
- acid
- aluminium
- glycyrrhetininc
- salts
- antacid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 abstract 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 229940069428 antacid Drugs 0.000 abstract 2
- 239000003159 antacid agent Substances 0.000 abstract 2
- 230000001458 anti-acid effect Effects 0.000 abstract 2
- 229960003720 enoxolone Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 abstract 1
- 208000007882 Gastritis Diseases 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001399 aluminium compounds Chemical class 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- UTUUIUQHGDRVPU-UHFFFAOYSA-K aluminum;2-aminoacetate;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Al+3].NCC([O-])=O UTUUIUQHGDRVPU-UHFFFAOYSA-K 0.000 abstract 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- -1 antacid aluminium compound Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 235000010216 calcium carbonate Nutrition 0.000 abstract 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- 235000014380 magnesium carbonate Nutrition 0.000 abstract 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 abstract 1
- 239000000347 magnesium hydroxide Substances 0.000 abstract 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 abstract 1
- 235000012254 magnesium hydroxide Nutrition 0.000 abstract 1
- 239000000391 magnesium silicate Substances 0.000 abstract 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 abstract 1
- 235000019793 magnesium trisilicate Nutrition 0.000 abstract 1
- 229940099273 magnesium trisilicate Drugs 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 230000001562 ulcerogenic effect Effects 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5835572A GB1401360A (en) | 1972-12-18 | 1972-12-18 | Pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38521L IE38521L (en) | 1974-06-18 |
| IE38521B1 true IE38521B1 (en) | 1978-03-29 |
Family
ID=10481403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2082/73A IE38521B1 (en) | 1972-12-18 | 1973-11-16 | Pharmaceutical composition |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU476390B2 (enExample) |
| BE (1) | BE802701A (enExample) |
| CA (1) | CA1018457A (enExample) |
| DE (1) | DE2360889A1 (enExample) |
| FR (1) | FR2210400B1 (enExample) |
| GB (1) | GB1401360A (enExample) |
| IE (1) | IE38521B1 (enExample) |
| IL (1) | IL42314A (enExample) |
| NL (1) | NL7317237A (enExample) |
| ZA (1) | ZA732439B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8307096A1 (es) * | 1981-06-01 | 1983-07-01 | Orion Yhtymae Oy | "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago". |
| GB2122893B (en) * | 1982-06-30 | 1985-06-26 | Biorex Laboratories Ltd | Glycyrrhetinic acid compositions |
| AU553789B2 (en) * | 1982-06-30 | 1986-07-24 | Biorex Laboratories Ltd. | Glycyrrhetinic acid derivatives in cream compositions |
| US4861591A (en) * | 1987-11-18 | 1989-08-29 | American Home Products Corporation | Formulations for hygroscopic pharmaceuticals |
-
1972
- 1972-12-18 GB GB5835572A patent/GB1401360A/en not_active Expired
-
1973
- 1973-04-09 ZA ZA732439A patent/ZA732439B/xx unknown
- 1973-05-20 IL IL42314A patent/IL42314A/en unknown
- 1973-07-23 BE BE133790A patent/BE802701A/xx not_active IP Right Cessation
- 1973-07-30 FR FR7327833A patent/FR2210400B1/fr not_active Expired
- 1973-11-16 IE IE2082/73A patent/IE38521B1/xx unknown
- 1973-11-30 AU AU63127/73A patent/AU476390B2/en not_active Expired
- 1973-12-06 DE DE2360889A patent/DE2360889A1/de not_active Withdrawn
- 1973-12-17 CA CA188,350A patent/CA1018457A/en not_active Expired
- 1973-12-17 NL NL7317237A patent/NL7317237A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2360889A1 (de) | 1974-06-20 |
| FR2210400B1 (enExample) | 1977-07-15 |
| IL42314A (en) | 1976-09-30 |
| GB1401360A (en) | 1975-07-16 |
| FR2210400A1 (enExample) | 1974-07-12 |
| IL42314A0 (en) | 1973-07-30 |
| ZA732439B (en) | 1974-03-27 |
| CA1018457A (en) | 1977-10-04 |
| AU476390B2 (en) | 1976-09-16 |
| AU6312773A (en) | 1975-06-05 |
| BE802701A (fr) | 1974-01-23 |
| IE38521L (en) | 1974-06-18 |
| NL7317237A (enExample) | 1974-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE38520B1 (en) | Pharmaceutical composition | |
| ES8102140A1 (es) | Un procedimiento para la preparacion de compuestos de cefem y cefam | |
| ES480605A1 (es) | Procedimiento para la obtencion de derivados o-sustituidos del (mas)-cianidanol-3. | |
| IE38521L (en) | Pharmaceutical composition | |
| IE33477B1 (en) | Naphthacene derivatives | |
| GB1246141A (en) | Improvements in or relating to -hydroxylproline derivatives | |
| WO1993020796A1 (en) | Method and composition for treating acne | |
| JPS5673089A (en) | Therapeutic creatinolloophosphate derivative* its manufacture* related pharmaceutic composition and therapy | |
| ES480146A1 (es) | Un procedimiento para la preparacion de derivados del acido pseudomonico. | |
| SU1251904A1 (ru) | Состав дл минерализации зубов | |
| GB906331A (en) | Appetite-reducing compositions comprising phenylamino propane derivatives | |
| US3787581A (en) | Pharmaceutical compositions and methods of treatment | |
| US3501577A (en) | Method of treating hypertension with alkali metal salts of zinc diethylenetriaminepentaacetate | |
| GB1265627A (enExample) | ||
| ES8305759A1 (es) | "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona". | |
| US3968145A (en) | Methyl 2(1 chloronaphth-2-yloxy)propionate | |
| GB1350929A (en) | Pharmaceutical compositions | |
| GB1276589A (en) | 0-alkyl-6-azauracil compounds and compositions containing the same | |
| Yendt | Drugs used in the management of renal calculi | |
| GB1464082A (en) | Pharmaceutical 'ompositions containing benzylamines | |
| GB1217822A (en) | Pharmaceutical compositions | |
| GB1342540A (en) | Sulphonic acid esters their preparation and their medicinal use | |
| GB1220793A (en) | Pharmaceutical compositions | |
| ES362779A1 (es) | Un procedimiento para la preparacion de un compuesto de 4- alcoxi-2,3-dihicro-1h-pirrolo (2,3-b) quinileina. | |
| GB1280244A (en) | Serum triglyceride-lowering compositions |